David Blaine Ridley
Associate Professor of the Practice of Business Administration
David Ridley is the Dr. and Mrs. Frank A. Riddick Professor of the Practice of Business. He is also the Faculty Director of Duke's Health Sector Management program. In his research, David examines innovation and pricing, especially in health care. He was the lead author of the paper proposing the priority review voucher program to encourage development of drugs for neglected diseases. The voucher program became law in the U.S. in 2007 and the market price of vouchers has been more than $100 million. David has published in economics journals (American Economic Journal: Economic Policy), medical journals (Journal of the American Medical Association), and scientific journals (Nature Reviews Drug Discovery). David teaches in the daytime MBA and executive MBA programs. He received a PhD in economics from Duke University in 2001.
- Ph.D., Duke University 2001
- M.A., Duke University 1995
- B.A., University of Missouri at Columbia 1993
Ridley, DB, and Régnier, SA. "The Commercial Market For Priority Review Vouchers." Health affairs (Project Hope) 35, no. 5 (May 2016): 776-783. Full Text
Ridley, DB, Dent, J, and Egerton-Warburton, C. "Efficacy of the Priority Review Voucher Program." JAMA 315, no. 15 (April 2016): 1659-1660. Full Text
Regnier, SA, and Ridley, DB. "Market watch: Forecasting market share in the US pharmaceutical market." Nature reviews. Drug discovery 14, no. 9 (September 2015): 594-595. Full Text
Gans, JS, and Ridley, DB. "Innovation incentives under transferable fast-track regulatory review." Journal of Industrial Economics 61, no. 3 (September 1, 2013): 789-816. Full Text
Ridley, DB. "Payments, promotion, and the purple pill (Accepted)." Health Economics (United Kingdom) (2013). Full Text
Ridley, DB. "Hotelling’s Law." In Palgrave Encyclopedia of Strategic Management,edited by D Teece and M Augier. 2013.
Towse, A, Keuffel, E, Kettler, HE, and Ridley, DB. "Drugs and Vaccines for Developing Countries." In The Oxford Handbook of the Economics of the Biopharmaceutical Industry. September 18, 2012. Full Text
Grabowski, HG, Ridley, David B., , Moe, and Jeffrey L., . "Encouraging innovative treatment of neglected diseases through priority review vouchers." In Prescribing Cultures and Pharmaceutical Policy in the Asia-Pacific,edited by K Eggleston,347-365. Stanford, CA: Stanford University: The Walter H, Shorenstein Asia-Pacific Research Center, September 1, 2009. Open Access Copy